I would continue to conduct research, but without relying on third-party funding or living from one temporary contract to another. Instead, I could devote my full attention to pre-clinical medical research by applying and developing state-of-the-art analytical strategies aimed at discovering next-level solutions for urgently needed pharmaceutical healthcare.